Open Label Extension Study

This type of study occurs upon completion of a clinical trial but before the request for FDA approval for the drug being studied. In an open label extension study, patients who participated in the initial randomized, placebo-controlled trial can be openly invited to take the drug for an extended period, regardless of whether they actually received the drug in the first trial.